GANIRELIX ACET 250 MCG/0.5 ML
For 1 mL
Pharmacies pay
$62.35 filed
1 × $62.34667 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-17, 2026-02-25 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$76.70 estimated
$62.35 + $9.35 (15%) + $5.00 fee per fill = $76.70
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2025-12-17, 2026-02-25 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
GANIRELIX ACET 250 MCG/0.5 ML is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ganirelix acetate.
FDA gives its dosage form as “injection” and “injection, solution” and its route as subcutaneous.
FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Amphastar Pharmaceuticals, Inc., Fresenius Kabi USA, LLC and Xiromed LLC.
FDA’s Established Pharmacologic Class for it is Gonadotropin Releasing Hormone Receptor Antagonist.
The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $62.35 for 1 mL (1 × $62.34667 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2025-12-17 and 2026-02-25. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
The NADAC of all 7 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2025-12-17, 2026-02-25. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
The 7 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Amphastar Pharmaceuticals, Inc. | 1 | $62.34667 per ML filed |
| Fresenius Kabi USA, LLC | 1 | $62.34667 per ML filed |
| Lupin Pharmaceuticals, Inc. | 1 | $62.34667 per ML filed |
| Meitheal Pharmaceuticals Inc. | 1 | $62.34667 per ML filed |
| Mullan Pharmaceutical Inc. | 1 | $62.34667 per ML filed |
| Organon LLC | 1 | $62.34667 per ML filed |
| Xiromed LLC | 1 | $62.34667 per ML filed |
When these prices took effect
- 2026-02-25 · 1 NDC, carried forward from an earlier file · $62.34667 per ML filed
- 2025-12-17 · 6 NDCs, all carried forward from an earlier file · $62.34667 per ML filed
All 7 NDCs, with labeler and price
- 00548-5001-00 · Amphastar Pharmaceuticals, Inc. · $62.34667 per ML · eff. 2025-12-17 filed carried forward
- 65219-0028-05 · Fresenius Kabi USA, LLC · $62.34667 per ML · eff. 2025-12-17 filed carried forward
- 70700-0327-98 · Xiromed LLC · $62.34667 per ML · eff. 2025-12-17 filed carried forward
- 70748-0274-01 · Lupin Pharmaceuticals, Inc. · $62.34667 per ML · eff. 2025-12-17 filed carried forward
- 71288-0554-80 · Meitheal Pharmaceuticals Inc. · $62.34667 per ML · eff. 2025-12-17 filed carried forward
- 78206-0138-02 · Organon LLC · $62.34667 per ML · eff. 2025-12-17 filed carried forward
- 83301-0082-01 · Mullan Pharmaceutical Inc. · $62.34667 per ML · eff. 2026-02-25 filed carried forward
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name ganirelix acetate with GANIRELIX ACET 250 MCG/0.5 ML.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| FYREMADEL 250 MCG/0.5 ML SYR | $62.34667 per ML filed | We don’t know yet |
| GANIRELIX ACET 250 MCG/0.5 ML this page | $62.34667 per ML filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-17, 2026-02-25 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 mL?
- The FDA package descriptions of this product’s NDCs give different amounts (0.5 mL, 1 mL). So the card starts at 1 ML; change it to match your prescription.